Smoking Cannabis May Cut Your Risk Of Non-Alcoholic Fatty Liver Disease: Study

Add non-alcoholic fatty liver disease (NAFLD) to the list of conditions that cannabis can help curb. 

A new study published in the journal PLoS One found that cannabis-friendly adults are less likely to develop the most prevalent form of liver disease – affecting 80 to 100 million Americans – than those without a history of cannabis use.  

Researchers from California’s Stanford University and South Korea’s Seoul National University College of Medicine looked at the relationship between cannabis and NAFLD in a nationally representative sample of more than 22,000 adults.

They found that cannabis use independently predicted a lower risk of suspected NAFLD in a dose-dependent manner.

“Active marijuana use provided a protective effect against NAFLD independent of known metabolic risk factors,” reads the study.

“[W]e conclude that current marijuana use may favorably impact the pathogenesis of NAFLD in US adults.”

These results reflect a study previously published in the same journal, which found that heavy cannabis consumers were 52 percent less likely – and occasional consumers 15 percent less likely – than non-users to suffer from NAFLD.

Another study published earlier this month in the Journal of Viral Hepatitis found that routine cannabis use is linked with a reduced prevalence of fatty liver disease in those with HIV and hepatitis C.

h/t NORML blog

Latest.

When marijuana edibles hit Canadian cannabis dispensary shelves later this year, you can expect them to be taxed based on how strong they are. Canada's recently released federal 2020 budget proposes to tax marijuana edibles based on the amount of THC they contain. THC is one of the active ingredients in cannabis and the one most associated with producing the plant's signature high.

Can we see some ID please?

You must be 19 years of age or older to enter.